Literature DB >> 23840048

Reply to Tsai et al.

Helen M Chun, Chloe L Thio, Brian K Agan, Michael L Landrum.   

Abstract

Mesh：

Year:  2013        PMID： 23840048      PMCID： PMC3762385          DOI： 10.1093/infdis/jit300

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  3 in total

1.  Hepatitis B virus coinfection negatively impacts HIV outcomes in HIV seroconverters.

Authors:  Helen M Chun; Mollie P Roediger; Katherine Huppler Hullsiek; Chloe L Thio; Brian K Agan; William P Bradley; Sheila A Peel; Linda L Jagodzinski; Amy C Weintrob; Anuradha Ganesan; Glenn Wortmann; Nancy F Crum-Cianflone; Jason D Maguire; Michael L Landrum
Journal:  J Infect Dis       Date:  2011-12-05       Impact factor: 5.226

2.  Hepatitis B surface antigen declines and clearance during long-term tenofovir therapy in patients coinfected with HBV and HIV.

Authors:  Roeland Zoutendijk; Hans L Zaaijer; Theodora E M S de Vries-Sluijs; Jurrien G P Reijnders; Jan W Mulder; Frank P Kroon; Clemens Richter; Annemiek A van der Eijk; Milan J Sonneveld; Bettina E Hansen; Robert A de Man; Marchina E van der Ende; Harry L A Janssen
Journal:  J Infect Dis       Date:  2012-07-10       Impact factor: 5.226

3.  Hepatitis B virus (HBV) coinfection accelerates immunologic progression in patients with primary HIV infection in an area of hyperendemicity for HBV infection.

Authors:  Mao-Song Tsai; Sui-Yuan Chang; Yi-Chun Lo; Chia-Jui Yang; Hsin-Yun Sun; Wen-Chun Liu; Pei-Ying Wu; Chien-Ching Hung
Journal:  J Infect Dis       Date:  2013-07-09       Impact factor: 5.226
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.